Market Signal Briefing

Fresh accumulation is emerging in Ethereum markets as whales, builders, and ETF investors add millions despite earlier sales by Vitalik Buterin.

Ethereum extended its recovery wave and surged over 8% in the last 24 hours to climb to almost $2,300 on Monday.

At the same time, blockchain data indicates fresh Ether purchases by a well-known early Bitcoin supporter.

Whales, Builders, and ETFs Pile Into ETH According to blockchain analytics platform Lookonchain, early Bitcoin supporter and founder of ShapeShift, Erik Voorhees, has resumed buying Ether after a one-year break. Data revealed that Voorhees spent 49.08 million USDT to purchase 23,393 ETH at an average price of $2,098 through two wallets. He still holds 35.25 million USDT.

The firm also added that he had offloaded 12,886 ETH last year when Ether was trading at approximately $3,320.

Lookonchain noted that other investors have also been accumulating Ether alongside Voorhees. A wallet linked to an early Ethereum builder, “billΞ.eth,” spent $17.46 million to purchase 7,769 ETH at an average price of $2,248 on Monday. On the same day, another whale identified as wallet 0x743d bought 1,827 ETH for $3.79 million. Over the past four days, the same whale has spent $24.79 million to acquire 11,985 ETH at an average price of $2,068.

The renewed accumulation trend comes as institutional demand for the asset has also strengthened. Data from spot Ethereum ETFs shows rising investor interest. These funds have recorded over $160 million in net inflows over the past week. During that period, four trading days registered positive inflows, while only one day posted net outflows.

Buterin’s ETH Sales On the other hand, Vitalik Buterin reduced some of his ETH holdings earlier this year. The Ethereum co-founder sold more Ether than he had originally planned. Buterin had previously announced a plan to sell 16,384 ETH, but on-chain data found total disposals reached about 18,684 ETH.

You may also like: Is Ethereum Waking Up? Binance ETH Turnover Hits 6-Month High as Volatility Returns Buterin Says Ethereum’s Biggest Bottlenecks Are State Tree and VM, Proposes Deep Fix The $6.1M Wallet: Inside LinkedIn Founder Reid Hoffman’s Ethereum Holdings The entire stash is worth over $38 million. The sales began in early February and occurred in several stages as ETH was gradually sold from his wallets. Buterin said the funds would be used to support open-source software and hardware development, privacy tools, and security-focused infrastructure projects. He also described the move as part of a period of “mild austerity” for the Ethereum Foundation.

Tags:

Bitcoin surged above $73,000 on Monday morning, following Bitcoin ETF inflows of $180.3 million on Friday, with Ethereum ETF inflows of $26.7 million.

Meme coin market capitalization spiked 4.9% to $35.4 billion over the past 24 hours.

Trader Commentary:

Crypto trader Jelle noted that Bitcoin started the week in positive territory and is attempting to print its eighth consecutive green daily candle.

Such extended streaks often precede large moves in either direction, with traders watching closely to see whether Bitcoin sweeps nearby equal highs, which could determine the next breakout or reversal.

Degen Hardy said Bitcoin is approaching a critical level, adding that a daily close above $74,000 would confirm bullish momentum. A rejection near that level, however, could signal a potential bull trap.

Crypto chart analyst Ali Martinez said Ethereum may be signaling the end of its downtrend after the SuperTrend indicator flipped from Sell to Buy for the first time since September. Historically, similar signals preceded rallies of 52% and 174%, with traders now watching $2,400 and $2,600 as the next key resistance levels.

Crypto Tony noted that Solana recently surged but may simply be testing the $77 supply zone. If the level flips into support, it could present a potential long opportunity.

Meanwhile, Martinez highlighted strong whale accumulation in Dogecoin, with 470 million DOGE purchased over the past 72 hours, signalling growing interest from large holders and possible bullish momentum.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Metaplanet said Monday it raised $255 million in a private placement and launched a new warrant structure to fund additional Bitcoin purchases.

Metaplanet raised about $255 million from institutional investors through a private placement of new shares, according to the company.

The private placement priced new shares at a 2% premium, paired with fixed-strike warrants at a 10% premium, which, if exercised, could add $276 million in additional capital as “firepower” toward the company’s goal of amassing 210,000 Bitcoin (BTC), according to CEO Simon Gerovich.

Metaplanet also issued a separate strike warrant offering on Monday, which may bring an additional $234 million of capital to fuel the accumulation strategy of the fourth-largest Bitcoin treasury company.

Source: Simon GerovichMetaplanet seeks $234 million via first-of-its-kind strike warrantsMetaplanet issued another 100 million in Moving Strike Warrants with what Gerovich called a first-of-its-kind Market Net Asset Value (mNAV) clause, which makes these exercisable only if the stock trades above 1.01x mNAV.

The offering enables the Bitcoin treasury company to raise another $234 million of capital for BTC purchases. The mNAV-tied clause aims to ensure that every newly issued share increases shareholder value, announced Gerovich earlier on Monday.

Metaplanet’s mNAV stood at 1.11x on Monday, above the key 1.01x threshold, as the company held 35,102 BTC ($2.5 billion) and its stock price was $2.45, according to Metaplanet’s dashboard.

The mNAV ratio compares a company’s enterprise value to the value of its crypto holdings. An mNAV below 1 makes it more challenging for companies to raise funds by issuing new shares, which may limit their cryptocurrency purchases.

Metaplanet MNAV, BTC holdings, share price. Source: MetaplanetThe new capital-raising mechanism is similar to the playbook used by Michael Saylor’s Strategy, the world’s largest corporate Bitcoin holder.

Strategy’s At-The-Market (ATM) common stock offering programs share similar mechanisms, allowing the company to raise capital by gradually issuing new common stock shares. Strategy only issues these shares when the mNAV is above 1x to avoid dilution.

In October 2024, Strategy disclosed plans to issue and sell shares of its class A common stock to raise up to $21 billion in equity and $21 billion in fixed-income securities over the next three years.

Magazine: Mysterious Mr Nakamoto author — Finding Satoshi would hurt Bitcoin

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Analysts at research and brokerage firm Bernstein said bitcoin is developing a more resilient ownership structure as institutional capital flows through exchange-traded funds and corporate treasury strategies reshape the market.

In a Monday note to clients, the analysts led by Gautam Chhugani said BTC has held up well during the recent Middle East conflict, outperforming traditional assets such as gold and global equity indices. Bitcoin rose roughly 7% last week, while Ethereum climbed about 9%, according to the report.

The analysts argue that maturity within the spot Bitcoin ETF cohort and demand from large corporate treasury buyers have transformed the asset’s investor base, reducing reliance on speculative retail capital and strengthening long-term prospects.

‘Bitcoin central bank of last resort’ A key contributor to that shift is Strategy, which Bernstein described as functioning as a “Bitcoin central bank of last resort” through its aggressive accumulation model.

The company has continued buying bitcoin through recent market volatility, adding more 66,231 BTC so far this year at an average cost near $85,000, the analysts said. Following it latest 8-K filing on Monday, Strategy's total holdings now stand above 761,000 BTC — valued at around $56 billion.

Strategy has also expanded financing structures tied to its bitcoin strategy, including preferred securities designed to attract income-focused investors. The firm’s STRC product pays an 11.5% dividend and has seen weekly trading volumes climb above $2 billion, according to the report. Capital raised through those instruments has helped fund additional bitcoin purchases.

Strategy's STRC weekly trading volumes | Image: Bernstein Bernstein said the company’s balance sheet remains heavily backed by the crypto asset, with roughly $57 billion in bitcoin and liquid cash against about $17 billion in debt.

At the same time, institutional demand has also accelerated through spot Bitcoin ETFs. Analysts estimate ETFs have absorbed about $2.1 billion in inflows over the past three weeks, leaving year-to-date outflows at roughly $460 million against a total ETF asset base of about $92 billion.

Those funds now control approximately 6.1% of the total bitcoin supply, according to Bernstein’s analysis.

Diamond hands The report also highlights the persistence of long-term holders as another stabilizing force in the market. Coins that have remained inactive for more than one year now account for roughly 60% of the circulating supply, a sign that a large share of investors view bitcoin primarily as a store-of-value asset.

Taken together, the analysts said these structural changes are strengthening bitcoin’s capital base even after periods of volatility. Roughly 14% of the total supply is now held by institutional vehicles, including ETFs, corporate treasuries, and governments.

Earlier this year, Bernstein argued that bearish narratives around bitcoin — including concerns about its four-year cycle and competition with gold — represented what the firm called the “weakest bitcoin bear case in history.” The firm at the time reiterated its long-term price target of $150,000 for 2026.

Bitcoin was trading near $70,000 when that forecast was reiterated in February. The asset is currently changing hands for around $73,600, according to The Block’s BTC price page.

Gautam Chhugani maintains long positions in various cryptocurrencies.

Disclaimer: The Block is an independent media outlet that delivers news, research, and data. As of November 2023, Foresight Ventures is a majority investor of The Block. Foresight Ventures invests in other companies in the crypto space. Crypto exchange Bitget is an anchor LP for Foresight Ventures. The Block continues to operate independently to deliver objective, impactful, and timely information about the crypto industry. Here are our current financial disclosures.

© 2026 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Japan’s most aggressive Bitcoin treasury company just got more aggressive.

Metaplanet CEO Simon Gerovich announced that the Tokyo-listed firm has raised approximately $255 million from global institutional investors through a placement of new shares priced at a 2% premium, paired with fixed-strike warrants at a 10% premium. If those warrants are fully exercised, that unlocks up to $276 million in additional capital, bringing total firepower to roughly $531 million, all directed toward its march to 210,000 BTC.

The numbers are significant. The structure is what makes this different.

The Interesting Clause You Should KnowAlongside the raise, Metaplanet has issued 100 million Moving Strike Warrants with what Gerovich calls a first-of-its-kind mNAV clause. Exercise is only permitted when the stock trades above 1.01x mNAV.

mNAV, or market-to-net-asset-value, measures a company’s stock price relative to the value of its Bitcoin holdings. By requiring the stock to trade above that threshold before any warrants can be exercised, Metaplanet has mathematically ensured that every share issued increases Bitcoin per share, not dilutes it.

Gerovich put it plainly: the structure “enables the company to raise an estimated $234M in additional capital to buy BTC, unlocked only when it’s accretive to BTC per share.”

Dylan LeClair, Metaplanet’s head of Bitcoin strategy, reposted the announcement. Notably, Metaplanet’s mNAV sits at 1.21x today, meaning the warrants are already in exercisable territory.

Where Metaplanet Stands vs StrategyMetaplanet currently holds 35,102 BTC, acquired at an average cost of $107,607 per coin. With Bitcoin trading at $73,177 today, those holdings sit underwater. The 210,000 BTC target remains a long way off.

Strategy, the benchmark for every corporate Bitcoin treasury, holds 738,731 BTC but trades at a discount to its Bitcoin holdings, meaning equity issuance there dilutes shareholders. Metaplanet’s premium mNAV flips that dynamic entirely, and this new warrant structure is designed to protect that premium.

The raise signals continued institutional appetite for corporate Bitcoin accumulation strategies.

Never Miss a Beat in the Crypto World!Stay ahead with breaking news, expert analysis, and real-time updates on the latest trends in Bitcoin, altcoins, DeFi, NFTs, and more.

FAQsWhat is Metaplanet’s Bitcoin treasury strategy?

Metaplanet is building a corporate Bitcoin reserve, aiming to accumulate 210,000 BTC as a long-term treasury asset to strengthen shareholder value.

How much Bitcoin does Metaplanet currently hold?

Metaplanet currently holds 35,102 BTC, purchased at an average price of about $107,607 per coin, as part of its plan to build a massive Bitcoin treasury.

Why is Metaplanet compared to Strategy in Bitcoin accumulation?

Metaplanet is often compared with Strategy because both companies focus on corporate Bitcoin reserves, though Strategy still holds far more Bitcoin overall.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

XRP price moved higher on Monday as cryptocurrency markets reacted to Bitcoin’s strong rebound above the $74,000 level. 

Bitcoin price climbed to nearly $74,300 during the rally, reaching its highest price in about 40-days.

The XRP price surged to around $1.50, surging by more than 5% while traders closely watch a possible rally toward the $2 level.

The total crypto market capitalization grew by $3.48% and stood at 2.52 trillion in the digital asset market. The larger market is going green too, with Ethereum +6.5%, Solana +5, and XRP +5 all showing significant presence in the large-cap altcoins. This coordinated major action tends to reflect a recovery in market confidence and risk taking.

In the meantime, CMC Crypto Fear and Greed Index has recovered to 40 (Neutral), which indicates that the sentiment has stabilized after two months of fearful circumstances.

Source: CoinMarketCap Investors are also keeping track of the next meeting of the Federal Reserve to see if the next move would be market oriented.

Bitcoin ETFs Draw $767M Weekly Inflows as XRP Transactions Near 3M Daily According to Sosovalue data, U.S. spot Bitcoin ETFs attracted $767 million in net inflows between March 9 and March 13.

The inflows extended Bitcoin ETF gain to three weeks of positive investor demand. Ether spot ETFs experienced a three week streak where Ethereum spot ETFs came in with $161 million of net inflows. Solana spot ETFs saw inflows of 10.7 million and reflected modest but consistent interest in the market.

From March 9 to March 13 (ET), Bitcoin spot ETFs recorded net inflows of $767 million, marking three consecutive weeks of net inflows. Ethereum spot ETFs saw $161 million in net inflows, also extending their three-week inflow streak. SOL spot ETFs posted $10.7 million in net… pic.twitter.com/slBc1GuHw6

— Wu Blockchain (@WuBlockchain) March 16, 2026

Nevertheless, XRP spot ETFs experienced a withdrawal of funds amounting to $28.07 million in the same reporting period. Analysis of network data reveals that XRP transactions are approaching 3 million per day as compared to 1 million in mid 2025. This tendency implies increased use of blockchain.

Source: Tweet XRP Price Eyes 36% Surge Toward $2 After Bullish Momentum Builds At the time of writing, the XRP price soared to $1.46 after buyers pushed the token higher.  The cryptocurrency moved upward after repeatedly holding support near the $1.45 level.

Technical indicators demonstrate positive strength with the MACD line moving above the signal line in the four-hour period.

The MACD positive histogram also widened, which showed increasing buying pressure and further upward movement.

Meanwhile, the Relative Strength Index rose to 70 with a very strong momentum in the overbought level.

Source: XRP/USDT 4-hour chart: Tradingview The confirmed breakout at a higher level of above $1.50 would further push XRP to a higher resistance level of $1.63. In case the momentum keeps rising, the XRP price might continue the rise to the resistance zone of $1.70.

The larger bullish formation on the chart indicates a significant upside objective at $2.00. At its present value, XRP would have to increase by approximately 36% to hit the mark of $2.

The support level of over $1.45 is still relevant to holding the existing bullish framework. On the downside, failure to hold the $1.45 support could trigger a decline toward the $1.40 level.

Bitcoin (BTC) found fresh strength during the early Asian trading hours on Monday as bulls eyed further short-term gains. 

Key takeaways:

Bitcoin price rises to a six-week high of $74,400 on Monday, liquidating $300 million in shorts.

The 50-day moving average above $71,120 is a key support level to watch for BTC/USD going forward.

Bitcoin leads market in new relief bounceData from TradingView showed 2.5% daily BTC price gains, with BTC/USD rising as high as $74,400 for the first time since Feb. 4.

BTC/USD one-hour chart. Source: Cointelegraph/TradingViewEther (ETH), the largest altcoin by market capitalization, was trading at $2,250 at the time of writing, up 7% over the last 24 hours. Fifth-placed XRP (XRP) has gained nearly 5% over the last day to trade just above $1.48.

Solana (SOL) has also posted significant gains among the top 10 cryptocurrencies, up 6% over the same period. As a result, the global crypto market capitalization is up 4% over the day to $2.49 trillion on Monday.

Performance of top-cap cryptocurrencies: Source: CoinMarketCap“Bitcoin pumped $1,800 in just 30 minutes, hitting a 40-day high of $74,300,” analyst Bull Theory said in the latest post on X, adding:

“It’s surprising how risk assets are performing better than safe-haven assets like gold and silver during an active war.”Bitcoin’s relief rally is accompanied by significant short liquidations across the crypto market totaling $300 million over the last 24 hours. Meanwhile, Bitcoin futures open interest (OI) continued to rise, with monitoring resource Coinglass showing a 6% jump to $49.2 billion in the past 24 hours.

Commenting on the data, Coinglass said that the same pattern of the OI rising in tandem with the price “preceded the last volatility spikes,” adding:

“New fuel is building again.”Bitcoin OI vs. price on Binance. Source: X/CoinGlass Bulls reclaim the 50-day BTC price trend lineBitcoin’s latest recovery saw it reclaim a key support level in the form of the 50-day simple moving average (SMA) at $71,120.

“Impressive strength on BTC today - set to close a daily candle above its 50MA for the first time in 55 days,” said trader and investor MacroSRG in a Monday post on X.

BTC rallied 33% in just a month following the last time the price reclaimed this trend line after a long period of trading below it.

BTC/USD daily chart. Source: Cointelegraph/TradingViewBitcoin is also “set to close 8 consecutive daily green candles for the first time since December 2020,” analyst Max Crypto said in an X post, adding: 

“Last time this happened, BTC rallied 145% in just 2 months.”Echoing this, MN Capital founder Michael van de Poppe said that while Bitcoin continues to build momentum, its valuation against gold “rallies substantially,” adding:

“There's more upside to come; $ETH broke out of the range, which means it's a matter of time until Bitcoin continues the rally towards $80K.”BTC/USD daily chart. Source: Michael van de PoppeAlong with the 50-day SMA, the BTC/USD pair now also trades above other key long-term levels, including the 200-week exponential moving average (EMA) and the old 2021 all-time high at $68,300 and $69,400, respectively.

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision. While we strive to provide accurate and timely information, Cointelegraph does not guarantee the accuracy, completeness, or reliability of any information in this article. This article may contain forward-looking statements that are subject to risks and uncertainties. Cointelegraph will not be liable for any loss or damage arising from your reliance on this information.

Solana finally broke out of the consolidation range after successfully flipping $90 into support. The altcoin jumped to a monthly high of $94.2 before a slight retracement. 

As of this writing, Solana [SOL] traded at $94.13, up 6.38% on the daily charts. In doing so, Solana flipped its EMA20 and was testing EMA50 at $94 at the same time.

Over the same window, volume climbed 102% to $4.37 billion, indicating increased market participation. These moves indicated strengthening upward momentum, as bulls gained ground.

Solana’s leverage is rising as risk appetite returns Solana has recently seen significant demand across all market participants, with many perceiving prevailing conditions as perfect entry points. 

This sentiment is extremely prevalent on the derivatives market, as traders have shown increased risk appetite. 

According to DeFiLlama data, Perps Volume recovered from a $280 million slip to surpass $600 million. Perpetual’s trading volume rose by over $300 million in two days, indicating increased speculation as traders aggressively positioned. 

Source: DeFiLlama On top of that, significant capital flowed into futures, as Futures Inflow jumped to $2.48 billion while outflow rose to $2.2 billion.

As a result, Futures Netflow surged 983% to $255 million. 

Source: CoinGlass With Perps volume and futures inflows rising in tandem, this suggested heightened speculative activity as traders deployed more capital. While capital flowed into positions, rising Leverage also signaled a potential cascade of liquidations. 

Buyers dip for a long haul On the Spot side, buyers have dominated the market over the past 30 days. As such, buyers have established a strong demand zone between $86 and $91.

The Spot Taker CVD data from CryptoQuant showed that buyers have largely remained active during the prolonged period of weakness.

Source: CryptoQuant On Binance in particular, buyers have significantly increased their accumulation. Over the past month, SOL recorded more than 206 million in buy volume, a trend that continued at press time.

On the 16th of March, the altcoin saw 5.4 million in buy volume on Binance, indicating strong demand. In fact, over $300 million flowed out of exchanges over the past 24 hours, a clear sign of aggressive spot accumulation.

Source: Coinalyze Can the momentum hold? Solana’s upside momentum strengthened as traders across the market stepped in amid broader improvements in sentiment.

For that reason, the altcoins’ RSI Cyclic Smoothed jumped above its Highband and rose to 62. A jump above these levels signaled the buyer’s commanding dominance in the market.

Source: TradingView At the same time, SOL jumped above its short-term moving average EMA20, further validating the trend’s strength. Usually, these market conditions point towards a potential trend continuation.

If demand holds, SOL could successfully retest EMA50 and eye a move above the key resistance of $100. However, if the move collapses and triggers mass liquidations, the altcoin could drop below $90 again, with $86 as support.

Final Summary Solana broke out of consolidation, flipping the $90 level into support and briefly reaching a monthly high near $94.2. Price momentum strengthened, with SOL trading around $94.13 after gaining 6.38% and reclaiming the EMA20 while testing the EMA50.

President Donald Trump’s family-backed crypto project, World Liberty Financial (WLFI) has passed a governance proposal requiring token holders to lock up their tokens for nearly six months in order to participate in protocol voting.

Summary

WLFI holders approved a governance proposal requiring token holders to stake their tokens for 180 days in order to participate in protocol voting. Participants who stake WLFI and vote at least twice during the lock period can earn roughly 2% annual yield. The proposal received overwhelming support and was approved with 99.12% of 1,800 votes cast in favor, although more than 76% of the voting power came from just ten users.

WLFI introduced the proposal last month, outlining a governance staking system that would require holders of unlocked WLFI tokens to stake their assets before they can participate in votes that determine the direction of the protocol and its broader ecosystem.

According to the firm, the change would ensure that only participants with “long-term alignment to the protocol” are able to influence governance decisions.

The proposal “rewards WLFI holders who have demonstrated the most commitment to WLFI governance and the WLFI ecosystem with additional opportunity to engage in the future of the WLFI ecosystem and potential commercial arrangements,” the document states.

Another goal of the initiative is to promote the adoption of WLFI’s USD1 stablecoin by redirecting value that previously flowed to market makers toward ecosystem participants.

To incentivize participation, the proposal introduces a base reward of roughly 2% annual yield for token holders who stake their WLFI and take part in at least two governance votes during the lock-up period. Meanwhile, holders whose tokens are already locked remain eligible to vote without additional staking requirements.

Further, the proposal documents outline a “Super Node” tier requiring participants to stake 50 million WLFI tokens, worth about $5 million, which would grant them “guaranteed direct access” to the WLFI team for collaboration and partnership discussions.

In a recent statement to Reuters, WLFI spokesman David Wachsman confirmed that the access would be limited to the project’s business development team and executives rather than direct engagement with specific founders. Trump’s sons Eric and Barron are listed in project materials as part of the team supporting the platform.

WLFI seeks banking charter, but faces hiccups As part of its longer-term plans centered around the USD1 stablecoin, the platform is also seeking a national trust bank charter from the U.S. Office of the Comptroller of the Currency.

The effort has drawn scrutiny from Washington lawmakers, with some arguing that the application should not move forward unless potential conflicts of interest tied to the project are addressed.

Concerns center on the project’s links to President Donald Trump and members of his family who are financially involved in the venture.

12h05 ▪ 4 min read ▪ by Evans S.

Summarize this article with:

Bitcoin regains strength as the rest of the market moves with much more hesitation. Amid geopolitical tension in the Middle East, the asset is having its best week since September 2025. This movement is not only based on a technical rebound. It also relies on the return of institutional flows and on a dynamic that is beginning to distinguish bitcoin from other major assets.

In brief Bitcoin posts its best week since September 2025. American ETFs clearly support the rebound The market remains cautious, but the dynamic is changing. Bitcoin regains control against traditional assets Bitcoin gained about 8.5% over the week and more than 13% since the escalation of the conflict in the Middle East. Meanwhile, American stocks, technology shares and even gold have held up significantly less well. This difference changes the market narrative.

For several months, bitcoin often behaved like a risky asset among others. Whenever macroeconomic pressure rose, it retreated along with tech stocks. This time, the behavior is different. It no longer mechanically aligns with the Nasdaq or software ETFs. It is starting to chart its own course.

This point is important because it shows an evolution in market perception. Bitcoin is not yet treated everywhere as a safe haven. That would be an exaggeration. However, it no longer appears simply as a speculative bet tied to growth stocks. It is precisely this gray area that attracts attention today.

ETFs revive American demand The other driver of the rebound comes from the United States. Bitcoin ETFs have recorded about 1.3 billion dollars of net inflows since the beginning of March. After several much more hesitant months, this return of institutional capital gives more weight to the movement.

This is not a detail. When ETFs attract new flows, they offer the market a more stable support than leveraged traders. This does not guarantee continuous growth, but it makes the rebound more credible. The market always prefers a rise fueled by real inflows rather than a simple squeeze on sellers.

The case of IBIT, BlackRock’s fund, illustrates this recovery well. Over five days, it has risen and approached a one-month high. Meanwhile, several assets considered defensive benchmarks or growth references have lost altitude. The contrast is clear. It strengthens the idea that bitcoin is becoming an asset closely watched by institutional investors again.

A solid rise, but a still nervous market However, it would be too easy to conclude that everything is bullish again. The market maintains a background of distrust. The crypto fear and greed index remains in extreme fear territory. This means that the current rebound is built without excessive euphoria. And that is both a strength and a limitation.

Funding rates for perpetual contracts also remain negative. In practical terms, this means short sellers still pay to maintain their positions. The dominant bias therefore remains cautious, even bearish, among some derivatives traders. This detail matters because it shows that the market does not yet fully believe in a sustainable reversal.

In short, bitcoin is moving forward, but it does so in a fragile psychological environment. It is often in such a context that the most powerful movements take shape. Not because everyone is convinced, but precisely because many still hesitate. The market climbs on the wall of doubt, not on collective intoxication. In addition, the demand from companies for bitcoin could far exceed the mined supply.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Evans S.

Fascinated by Bitcoin since 2017, Evariste has continuously researched the subject. While his initial interest was in trading, he now actively seeks to understand all advances centered on cryptocurrencies. As an editor, he strives to consistently deliver high-quality work that reflects the state of the sector as a whole.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Digital asset investment products pulled in $1.06 billion last week, extending a three-week inflow streak that has challenged Bitcoin’s critics during a period of acute geopolitical stress.

The latest CoinShares weekly report showed total exchange-traded product (ETP) assets climbing 9.4% to $140 billion since tensions with Iran escalated, reinforcing a growing institutional view that Bitcoin (BTC) functions as a relative safe haven.

US Investors Drive the Surge As Bitcoin Dominates, but Sentiment Stays SplitBased on the report, American funds accounted for 96% of total inflows. Canada added $19.4 million, and Switzerland contributed $10.4 million. Hong Kong posted $23.1 million, its strongest week since August 2025.

Germany bucked the trend, recording $17.1 million in outflows, the first weekly withdrawal from the country this year.

Bitcoin products attracted $793 million, or 75% of total flows. The three-week cumulative tally now sits at $2.2 billion, nearly closing the gap with the $3 billion that exited during the prior five-week downturn.

Crypto Fund Flows by Asset. Source: CoinSharesHowever, short-BTC products also drew $8.1 million, a signal that some investors remain cautious despite the broader rally.

Ethereum Gets a Staking BoostEthereum (ETH) recorded $315 million in inflows, partly driven by BlackRock’s launch of the iShares Staked Ethereum Trust ETF (ETHB) on March 12.

The new product allows investors to earn staking rewards while also gaining spot price exposure.

Year-to-date ETH flows have now returned close to neutral after heavy outflows earlier in 2026.

XRP extended its losing streak with $76 million in outflows for a second consecutive week, suggesting the altcoin rotation that dominated late 2025 may be losing steam.

Cover image via www.freepik.com Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Strategy Inc. has started trimming some of the losses incurred when the leading crypto asset, Bitcoin (BTC), dipped to a monthly low of $62,553. The bearish outlook of Bitcoin and unrealized losses had reignited criticism of Michael Saylor’s use of Bitcoin as a hedge.

Bitcoin rebound cuts Strategy's massive drawdownHowever, CoinMarketCap data signals that Strategy’s portfolio has improved significantly by 8.7% as Bitcoin regained the $74,000 level. Notably, the price of BTC soared from a low of $71,282.33 to an intraday peak of $74,395.78.

That massive surge proved sufficient to minimize Strategy’s losses on the crypto investment market. The business intelligence firm currently holds a total of 738,731 BTC as of its last acquisition. The average price of each Bitcoin cost Strategy $75,862.

Hence, with Bitcoin plummeting to a monthly low of $62,533, Strategy’s drawdown was approximately $10 billion at $9,846,545,499.

However, with a renewed rally from the leading digital asset, Strategy has been able to trim a huge chunk of that loss. Although the firm is still in troubled waters, it is no longer neck-deep in losses, as Bitcoin’s price is gradually climbing to the firm’s average buying price per coin.

It is worth mentioning that the volatility of Bitcoin remains a troubling concern, and until BTC stabilizes above $80,000, investors might continue to express concerns.

You Might Also Like

Michael Saylor maintains long-term "Bitcoin Over Everything" visionAs of this writing, Bitcoin has slipped and exchanges hands at $73,242.51, which represents a 1.92% increase in the last 24 hours. 

Within the same time frame, trading volume has soared by 93.66% to $40.84 billion as institutional interest reignites, creating sustained buying pressure.

The uptick has also revived the interest of traders, who buy whenever there is a rally and do not want to miss out on potential profits.

Bitcoin’s rebound move validates Michael Saylor’s unwavering belief in the maxim, "Bitcoin over everything." The Bitcoin optimist has continued to remain positive that the asset will reclaim previous price levels. This has fueled his regular purchase of Bitcoin as Strategy chases a one million BTC portfolio.

Bitcoin pushed back above the $74,000 mark, returning to price levels last seen in early February. On March 16, the BTC price on Bitstamp reached $74,425, its highest level since February 4.

Bitcoin (BTC) Price. Source: CoinCodex.The move capped a strong week for the cryptocurrency. Bitcoin gained 10.3% over the past seven days, while the weekly candle closed above the 200-week exponential moving average (EMA), a long-term technical level that many traders view as the dividing line between bull and bear markets.

The breakout was spotted in real time by analysts at The Kobeissi Letter, who highlighted the strength of the move as Bitcoin regained key momentum levels.

Ethereum also followed the rally. Market commentator Ash Crypto noted that ETH climbed to $2,250, signaling renewed strength across the broader crypto market.

Seven Green Days Put Traders on AlertThe technical structure is reinforcing bullish sentiment. Bitcoin has now closed seven consecutive daily candles in positive territory, a rare streak in the market.

Investor Crypto Rover pointed out that a similar run of green candles was last seen after the market formed a bottom during previous macro shocks.

BTC/USD 1-Day Chart. Analysis: Crypto Rover.Bitcoin is now attempting to close its eighth consecutive green session, something that often precedes a sharp market move.

What usually happens after such streaksTrader Jelle noted that extended streaks like this tend to resolve in one of two ways:

a strong continuation rally, ora sharp corrective move after momentum overheats.For now, analysts are watching the daily close and potential tests of recent highs to determine the next direction.

Not every trader expected this outcome. Market participant Ed_NL admitted that last week’s price action surprised him, as he had anticipated a pullback before Bitcoin reached the current resistance area.

Instead, the market moved higher much sooner than expected.

Bitcoin Diverges From Traditional MarketsBitcoin’s latest rally has also stood out because it came while traditional markets weakened.

According to Bitfinex, Bitcoin gained more than 4% over the weekend, even as major stock indices declined. At the same time, oil prices surged past $100 per barrel amid growing tensions in the Middle East.

BTC/USD 4-hour chart. Analysis: Bitfinex.Analysts from Bitfinex Alpha noted that this divergence between Bitcoin and equities has begun to emerge during periods of geopolitical uncertainty. The key question now is whether the trend continues.

Another signal catching analysts’ attention is the behavior of large holders.

Data from the CryptoQuant analytics platform shows that the Exchange BTC Whale Ratio, which measures the share of large transactions on exchanges has reached its highest level in six years.

Historically, increases in this indicator often appear near short-term market bottoms, while peaks can signal the early stages of a new upward trend.

CryptoQuant founder and CEO Ki Young Ju added that sentiment among many Bitcoin analysts has recently turned decisively bullish.

Whether the current rally evolves into a sustained breakout or pauses after its strong momentum streak may become clearer in the coming sessions.

The Bitcoin and Ethereum prices continue to struggle, with BTC dropping to as low as $70,000 over the weekend. This comes as tensions between the U.S. and Iran continue to escalate, with no sign of a ceasefire happening anytime soon. 

Bitcoin and Ethereum Prices Struggle as Iran War Drags On Bitcoin and Ethereum prices remain under pressure as the war in Iran enters its third week. Tensions escalated over the weekend with attacks on the U.S. embassy in Iraq, according to a Fortune report. The U.S. embassy had indicated that these attacks were carried out by Iran-aligned terrorist ‌militia groups. 

Notably, the attacks on the U.S. embassy came amid America’s airstrikes on Iran’s Kharg Island, a key oil terminal for the country. The Bitcoin and Ethereum prices notably fell following the U.S. strikes on the Island. The strikes sparked concerns that it could further drive oil prices higher, which is bearish for BTC and ETH. 

Brent crude oil futures have already risen to as high as $106 today, according to TradingView data, in response to U.S. strikes on Kharg Island. Oil prices could also continue to rise as the Strait of Hormuz, a key oil chokepoint, remains effectively closed. About 20% of the global oil supply passes through the Strait, which is why its closure could spark a massive supply shock and lead to new highs. 

Source: Chart from TradingView  Market analyst XWIN Research warned that Bitcoin could face significant outflows if the Strait of Hormuz remains closed, which would put pressure on not just BTC but the Ethereum price and other crypto assets. In an interview on ABC’s ‘This Week,’ U.S. Energy Secretary Chris Wright warned that there are no guarantees that oil prices would fall in the coming weeks.

Meanwhile, the Bitcoin and Ethereum prices are also facing pressure, with the Fed unlikely to cut interest rates at this week’s FOMC meeting. There are also concerns that the FOMC could further delay in cutting rates due to the rising oil prices, which threaten to drive inflation higher.  

Peter Brandt Predicts That A Rally May Be On The Cards Veteran trader Peter Brandt has suggested that Bitcoin could see a relief rally even amid the U.S.-Iran war. In an X post, he shared an accompanying chart showing BTC could reach as high as $88,000. BTC and the Ethereum prices may already be seeing this relief rally, with these crypto assets up over 3% and 7%, respectively, today. 

Crypto analyst Julio Moreno had earlier warned that the crypto market is still in a bear market despite any potential relief rallies for the Bitcoin and Ethereum prices. Expert Benjamin Cowen echoed a similar sentiment, noting that BTC often spends more time going up than down. He added that when the flagship crypto goes down, it goes down very quickly, sets a low, and then trends up for a week before going lower.

BTC trading at $73,685 on the 1D chart | Source: BTCUSDT on Tradingview.com Featured image from Pixabay, chart from Tradingview.com

Bitcoin climbed back into the $73,500 to $73,800 resistance band over the weekend, reaching its highest level since the Iran war and Trump tariff turmoil began to shake global markets.

The move comes even as crude remains above $100, supply through the Strait of Hormuz has been disrupted, and investors have cut back expectations for Federal Reserve rate cuts.

As of press time, CryptoSlate data shows Bitcoin at about $70,470, up 0.33% over 24 hours, 1.09% over seven days, and 5.7% over 30 days.

The price action stands out because the chart structure does not yet show a clean trend in the market. The market has mostly respected defined reaction zones.

About three-quarters of all tests of support and resistance levels over the last few months have ended in rejection rather than acceptance. That gives the current test of the upper band a narrower meaning than a simple breakout call. Bitcoin has repaired the panic damage. It still has to prove it can stay above the panic ceiling.

The clearest near-term resistance sits at $73,500 and $73,800. Those two levels form a top channel pair in the active zone and have produced repeated rejections in the recent stretch of the data.

The first support band below sits at $72,000 and $71,500. Below that, $68,000 remains the next major line where price repeatedly found buyers during February and early March.

The immediate question is whether Bitcoin can convert resistance into support, given the still-hostile macro backdrop.

That backdrop has not eased. Oil has surged after the Iran conflict disrupted flows, with AP reporting disruption of more than 12 million barrels per day across the Gulf system. The same shock has fed into inflation expectations and raised doubts about how much room the Fed has to cut this year.

Bitcoin is rising into a heavy resistance band before the outside world has improved. The structure says buyers have regained control of the upper half of the range. It does not yet show that they have escaped it.

Support, resistance, and the difference between a break and acceptanceThe recovery through $68,000 looks accepted. So does the later move back through $71,500 and $72,000. Those levels did not hold as one-off spikes. Price spent time above them, built higher lows, and kept returning to the upper part of the structure.

That sequence carries more weight than the latest wick into the $73,500 to $73,800 band because it shows where buyers already proved they would defend the market.

The current move into $73,500 and $73,800 looks more vulnerable. The data is bounce-heavy, the overhead zone is tight, and the market is reaching it while oil, inflation, and trade-policy stress are still unresolved. A rejection here would fit the pattern better than an immediate straight-line run to the next band.

ZoneRole nowWhat the data suggests$73,500 to $73,800Primary resistanceRepeated recent rejection area, needs a hold above to count as acceptance$72,000 to $71,500Primary supportMost important near-term floor after the recovery from the panic selloff$68,000Secondary supportMajor reaction level during the mid-range consolidation$77,100Next upside targetOpens only if price accepts the current upper bandThe broader market picture offers a partial explanation for why Bitcoin could keep pressing higher even in that setup. U.S.-listed Bitcoin ETFs did not lose their demand base during the latest macro shock.

After outflows of $227.9 million on March 5 and $348.9 million on March 6, the funds posted five straight positive sessions: $167.1 million on March 9, $246.9 million on March 10, $115.2 million on March 11, $53.8 million on March 12, and $180.4 million on March 13. Those figures show that larger buyers did not disappear when macro pressure rose.

That distinction helps frame the current setup. If ETF demand had collapsed at the same time price hit the upper band, the chart would look more like a short-covering bounce running out of fuel. Instead, the latest flow numbers show steady support from fund inflows while Bitcoin retests the highs of the post-shock recovery.

That is one reason the $72,000 to $71,500 floor now carries more weight than the latest intraday print above $73,500. Support shows where buyers are willing to defend size. Resistance shows where sellers are still active.

In that sense, the most important recent move was the reclaiming of $71,500 and $72,000 after the macro panic, rather than reaching $74,000. That recovery showed that buyers were willing to absorb supply while the oil shock was still live and rate-cut expectations were still being marked down.

What the macro backdrop changes, and what it does notThe macro climate still argues for caution. The oil shock continues to ask questions about inflation, growth, and how long high rates might stay in place.

CryptoSlate Daily Brief

Daily signals, zero noise.Market-moving headlines and context delivered every morning in one tight read.

5-minute digest 100k+ readers

Free. No spam. Unsubscribe any time.

You’re subscribed. Welcome aboard.

Recent FT reporting cited estimates that put the likely inflation effect at 0.5 to 0.6 percentage points, while projecting a 0.3-point hit to global GDP growth. The Fed is still expected to hold rates steady, with markets rethinking how many cuts remain plausible this year.

Meanwhile, the Trump tariff fight is still running. The Supreme Court decision that disrupted key tariff measures has forced the administration to reopen trade probes and look for new legal paths.

Put simply, the outside-world pressure has not gone away. Bitcoin is rising while the macro picture remains messy.

The base case from the channel data is a range-acceptance fight between $72,000 and $73,800. Buyers have already shown they can defend the lower part of that band. Sellers have not yet given up the upper edge. If that continues, Bitcoin can keep grinding higher in steps without producing a decisive breakout.

The bull case needs more than a print above resistance. It needs time above resistance. If Bitcoin holds $73,500 on a retest and stops falling back under $73,800, the next obvious structural target is $77,100. That level sits as the next upper channel boundary in the framework and would be the first place to test whether the move is becoming a broader trend rather than another rejection cycle.

The bear case is simpler. A rejection from $73,500 to $73,800, followed by a loss of $72,000, would bring $71,500 back into focus. If that fails, the market would likely revisit $68,000, which has served as the most durable support line. That would not erase the medium-term recovery, but it would weaken the view that Bitcoin is already trading as a stronger macro hedge through this shock.

There is also a low-probability, high-impact case that sits outside the chart. If the Iran conflict widens further, if oil spikes again, or if rate expectations reset sharply higher, forced selling could overwhelm the channel structure in the short run. The chart would still matter, but headline risk would likely take over first.

What comes next for BitcoinThe most defensible conclusion from the data is that Bitcoin has staged a real recovery but has not completed a clean breakout.

The upper resistance band is still the key test. Traders who want confirmation should watch for acceptance above $73,500 and $73,800, not just another touch. Traders looking for early weakness should watch whether the market can still hold $72,000 on the next pullback.

That leaves the market with a straightforward map.

ScenarioTriggerLikely pathBase caseBitcoin holds $72,000 but fails to stay above $73,800Range trade continues, with repeated tests of the upper bandBull caseBitcoin holds above $73,500 after a breakoutPrice targets $77,100 as the next clear channel boundaryBear caseBitcoin rejects the upper band and loses $72,000Price retests $71,500, with $68,000 back in playMacro shock caseWar, oil, or rates worsen sharplyHeadline risk overrides the range and raises liquidation riskFor now, the clearest take is simple. Bitcoin has climbed back to the top of its recent range even as war, oil, inflation pressure, and tariff uncertainty continue to pull on global markets. The recovery through $68,000, $71,500, and $72,000 looks real. The market has not yet shown the same acceptance above $73,500 and $73,800.

If Bitcoin can live above that band, $77,100 becomes the next measured target inside this framework.

If it cannot, the move still looks like a strong recovery inside a range that has rejected the price more often than it has released it.

Mentioned in this articlePosted in

Bitcoin price has moved above $74,000 on Monday morning as corporate demand and supply trends drew market attention. Amid the recovery, Japanese investment firm Metaplanet has announced a $255 million capital raise aimed at expanding its Bitcoin holdings.

The company secured the funding through a private placement with global institutional investors. The new capital supports Metaplanet’s long-term strategy to accumulate Bitcoin and reach a target of 210,000 BTC.

According to an X post, the Japanese firm Metaplanet has raised about $255 million through a third-party private placement. The shares were issued at a 2% premium to market price.

Per the report, the funding round also included fixed-strike warrants priced at a 10% premium. These warrants could generate up to $276 million in additional capital if exercised.

Chief Executive Officer Simon Gerovich said the structure allows the company to raise funds while managing stock volatility. He wrote, “Metaplanet has raised ~$255m from global institutional investors via a placement of new shares priced at a 2% premium.”

He added that the warrants could bring “up to ~$276m in additional capital upon exercise.” This would provide more resources for the company’s Bitcoin acquisition plan. In total, the arrangement could give the firm as much as $531 million in new capital for Bitcoin purchases.

Metaplanet also issued moving strike warrants for up to 100 million shares. These warrants include a clause tied to the company’s modified net asset value. The warrants can only be exercised if the stock price trades at least 1.01 times its modified net asset value. The condition ensures that new shares increase value per share.

As per the company, the warrants could add about 37.1 billion yen in extra funding if conditions are met, and hence be used to acquire Bitcoin. Metaplanet noted that the mechanism ensures each issuance supports growth in Bitcoin held per share. This approach links fundraising directly to treasury expansion.

The strategy reflects a growing trend among public companies that use equity markets to build Bitcoin reserves. As of March 16, Metaplanet holds 35,102 BTC, which are valued between $2.4 billion and $2.59 billion, depending on market price. 

This position represents about 0.167% of Bitcoin’s total 21 million supply and hence is currently the fourth-largest public corporate Bitcoin holder. Strategy, which the firm has implemented its ways, remains the largest corporate holder, holding about 738,731 BTC acquired through more than 100 purchases since 2020.

As per Bitcoin Treasuries, Metaplanet’s average acquisition cost stands at $107,716 per Bitcoin. Despite being 31% in loss so far, the firm’s roadmap aims for 100,000 BTC by 2026 and 210,000 BTC by 2027, which would represent roughly 1% of the total Bitcoin supply.

Analysts Outline Potential BTC Price Path Toward $80K Market analysts say Bitcoin’s reclaim of $74,000 has revived bullish expectations. Several traders view the level as a confirmation that recent support near $60,000 held.

Crypto analyst Crypto Patel noted that Bitcoin bounced exactly from that support zone. He wrote, “Bitcoin did exactly what I said. ~$74,000 reclaimed. The roadmap isn't done yet.”

According to his outlook, the next major target sits near $80,000. A further move could push prices toward the $88,000 to $92,000 range if momentum continues.

Source: X

Patel also warned that a break below $60,000 could change the outlook. In that scenario, he expects a possible retracement toward a $45,000 to $50,000 institutional accumulation zone.

On-chain data also supports a tightening supply environment. Analytics platform Santiment reported that the percentage of Bitcoin held on exchanges has dropped to its lowest level since November 2017.

Lower exchange supply often reflects long-term holding behavior. When fewer coins remain on trading platforms, selling pressure may decline during rallies, and hence maintain the bullish shift.

European publishers, tech firms and startups have urged EU antitrust regulators to wrap up a near two-year probe into Alphabet unit Google's alleged favouring ​of its own services in online searches and impose a fine on the ‌tech giant.

Honda Motor Co., Ltd. (HMC) Q4 2026 Press Conference Call March 12, 2026 3:30 AM EDT

Company Participants

Toshihiro Mibe - President, CEO, Representative Executive Officer & Chairman
Noriya Kaihara - EVP, Representative Exe Off, Culture Transformation Officer, Compliance & Privacy Officer, Director
Eiji Fujimura - Managing Executive Officer, CFO, Chief Officer of Corporate Admin. Operations & Director

Presentation

Operator

Thank you for your attendance today despite such a short notice. Now I would like to -- we would like to hold a press conference regarding the timely disclosure in the press release announced today at 3:30. First, we would like to introduce attendants today. Director, President and Representative Executive Officer, Toshihiro Mibe; Director Executive Vice President and Representative Executive Officer, Noriya Kaihara; Director, Managing Executive Officer, Eiji Fujimura.

First, Mibe will walk you through the background that led to the management decision this time, followed by Kaihara's explanation of the future direction towards the construction of Honda's automobile business in mid- to long term.

Now the floor is yours, Mibe-san.

Toshihiro Mibe
President, CEO, Representative Executive Officer & Chairman

Good afternoon, ladies and gentlemen. This is Mibe speaking. Thank you for taking time to join us despite the short notice.

As you may have come to know through sources such as our news release today, we announced a forecast revision in the fiscal year ending March 31, 2026. Though challenging, we will explain the background of this decision and future direction for rebuilding the mid- to long-term automobile strategy.

Honda has been working to realize carbon neutrality by 2050. To this end, led by small-sized mobility products, including passenger cars, Honda shifted strategic direction towards EV popularization based on our belief that EVs will be the optimal long-term solution. In this journey, we anticipated increasingly stringent environmental regulations would come into full effect in various countries

Semtech Corporation (NASDAQ:SMTC) will release earnings results for its fourth quarter, after the closing bell on Monday, March 16.

Analysts expect the Camarillo, California-based company to report quarterly earnings at 43 cents per share, up from 40 cents per share in the year-ago period. The consensus estimate for Semtech's quarterly revenue is $273.2 million, versus $251 million a year earlier, according to data from Benzinga Pro.

On March 10, Semtech announced a partnership with Digital Barriers to launch Semtech Video Compression, a fully integrated device-to-cloud cellular video solution designed for surveillance and analytics applications.

Semtech shares rose 1.7% to close at $84.85 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Considering buying SMTC stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Global ​demand for ‌liquefied natural gas ​is ​estimated to rise ⁠by ​54-68% ​by 2040 and 45-85% ​by ​2050 from 422 ‌million ⁠metric tons in 2025, ​Shell ​said ⁠on Monday.

Discount retailer Dollar Tree forecast ‌annual sales largely below expectations on Monday, as budget-conscious consumers tightened spending.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (“Janus Living”), announced today that Janus Living has launched its initial public offering of 37,000,000 shares of its Class A-1 common stock pursuant to a registration statement on Form S-11 filed with the Securities and Exchange Commission (the “SEC”). The initial public offering price is expected to be between $18.00 and $20.00 per share. Janus Living expects to grant the underwriters a 3.

ST. LOUIS--(BUSINESS WIRE)--Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.07 per share to be paid on April 10, 2026, to shareholders of record as of March 26, 2026. Caleres has paid consecutive quarterly dividends for over a century, reflecting a core commitment to shareholders and a testament to the company's financial strength. About Caleres Caleres is a marke.

BROOKFIELD, NEWS, March 16, 2026 (GLOBE NEWSWIRE) -- Brookfield Business Partners L.P. (“BBU”) and Brookfield Business Corporation (“BBUC”) announced today that they have received all required approvals to complete the previously announced corporate simplification to convert into one publicly traded Canadian corporation.

“Today represents an important milestone in the continued growth and evolution of our business as we near the completion of simplifying our corporate structure,” said Anuj Ranjan, CEO of Brookfield Business Partners. “We expect the benefits of converting into a single listed corporate entity – including greater index inclusion and improved trading liquidity will help broaden our global investor base and support our continued focus on creating long-term value for our shareholders.”

The court-approved plan of arrangement is expected to become effective prior to markets open on March 27, 2026. On closing, all BBU limited partnership units, BBUC Class A exchangeable shares and redemption-exchange units held by Brookfield will be exchanged for newly issued Class A shares of the new Canadian corporation on a one-for-one basis. The new corporation will assume the name Brookfield Business Corporation.

Following completion of the reorganization, the newly issued Class A shares of Brookfield Business Corporation are expected to commence trading on the New York Stock Exchange and the Toronto Stock Exchange under the symbol “BBUC” on March 31, 2026.

About Brookfield Business Partners
Brookfield Business Partners is a global business services and industrials company focused on owning and operating high-quality businesses that provide essential products and services and benefit from a strong competitive position. Investors currently have flexibility to invest in our company either through Brookfield Business Partners L.P. (NYSE: BBU; TSX; BBU.UN), a limited partnership, or Brookfield Business Corporation (NYSE, TSX: BBUC), a corporation. For more information, please visit https://bbu.brookfield.com.

Brookfield Business Partners is the flagship listed vehicle of Brookfield Asset Management’s Private Equity Group. Brookfield Asset Management is a leading global alternative asset manager with over $1 trillion of assets under management.

For more information, please contact:

Media:
Marie Fuller
Tel: +44 207 408 8375
Email:[email protected]
Investors:
Alan Fleming
Tel: +1 (416) 645-2736
Email:[email protected]
Cautionary Statement Regarding Forward-looking Statements

This news release contains “forward-looking information” within the meaning of Canadian provincial securities laws and “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, include statements regarding the anticipated closing date of the reorganization transaction; and the commencement of trading of the newly issued Class A shares on the New York Stock Exchange and the Toronto Stock Exchange, and include words such as “expects”, “anticipates”, “plans”, “believes”, “estimates”, “seeks”, “intends”, “targets”, “projects”, “forecasts”, “views”, “potential”, “likely” or negative versions thereof and other similar expressions, or future or conditional verbs such as “may”, “will”, “should”, “would” and “could”. Although Brookfield Business Partners believes that these forward-looking statements and information are based upon reasonable assumptions and expectations, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Factors that could cause actual results of Brookfield Business Partners to differ materially from those contemplated or implied by the statements in this news release include risks and factors described in the documents filed by BBU and BBUC with securities regulators in Canada and the United States including under “Risk Factors” in BBU’s and BBUC’s most recent Annual Reports on Form 20-F and the joint management information circular of BBU and BBUC filed in connection with the reorganization transaction and other risks and factors that are described therein. Except as required by law, Brookfield Business Partners undertakes no obligation to publicly update or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise.

In the Phase 3 ADorable-1 study, 63% of patients achieved meaningful skin improvement (EASI-75) and 44% achieved clear or almost clear skin (IGA 0,1) at Week 16

In key secondary endpoints, 39% of patients achieved a high bar of near-complete skin clearance (EASI-90) and 35% achieved significant itch relief (Pruritus NRS ≥4-point improvement)

The safety and tolerability profile of EBGLYSS was consistent with adult and adolescent studies, with no injection site pain reported

, /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive, topline results from the Phase 3 ADorable-1 trial evaluating the safety and efficacy of EBGLYSS (lebrikizumab-lbkz) in pediatric patients with moderate-to-severe atopic dermatitis. EBGLYSS met the primary and key secondary endpoints at Week 16, improving disease severity while delivering skin clearance and relief from persistent itch. Atopic dermatitis is more common in children than adults, affecting 9.6 million children in the U.S., one-third of whom have moderate-to-severe disease.1 Lilly plans to submit these data to U.S. and global regulators for a potential label update.

EBGLYSS is an interleukin-13 (IL-13) inhibitor that selectively blocks IL-13 signaling with high binding affinity and slow dissociation rate.2,3,4 The cytokine IL-13 is a primary cytokine in atopic dermatitis, driving the type-2 inflammatory cycle in the skin, leading to skin barrier dysfunction, itch, skin thickening and infection.5,6

In ADorable-1, participants were randomized to receive placebo or a weight-based dose of EBGLYSS. Topical corticosteroids were required beginning two weeks before randomization and throughout the 16-week study but could be decreased or stopped once patients achieved IGA 2 or less. The co-primary endpoints in ADorable-1 were EASI-75 and IGA 0,1 at Week 16. Key secondary endpoints included an even greater clinical improvement in disease severity (EASI-90) and itch relief (Pruritus NRS ≥4-point improvement).

Key efficacy results in ADorable-1 at Week 16

EBGLYSS*     

Placebo     

EASI-75**

63 %

22 %

IGA 0,1 and a reduction ≥2 points from baseline†   

44 %

15 %

EASI-90‡

39 %

11 %

Pruritus NRS ≥4-point improvement§ in patients
6 years and older with score ≥4 at baseline

35 %

6 %

*

Includes all EBGLYSS dosing regimens

**

EASI=Eczema Area and Severity Index; EASI-75=75% reduction in EASI from baseline

†

IGA 0,1=Investigator's Global Assessment 0 or 1 ("clear" or "almost clear")

‡

EASI-90=90% reduction in EASI from baseline

§

Pruritus NRS=Numeric Rating Scale rating itch from 0-10 with 10 being worst imaginable itch
within the past 24 hours

"Children with moderate-to-severe atopic dermatitis often endure relentless skin flares, itch and discomfort that can disrupt play, school and daily life for patients and caregivers," said Adrienne Brown, executive vice president and president, Lilly Immunology. "EBGLYSS has already changed what's possible for adults and adolescents, delivering durable results that help patients flare less with the option of monthly maintenance dosing. Now, these data show EBGLYSS also provided disease control in pediatric patients, a critical milestone that, if approved, could bring profound relief to these patients and their families."

The safety of EBGLYSS was consistent with the known profile in adult and adolescent patients, with no new safety signals observed. The most common adverse events occurring in ≥5% of participants were upper respiratory tract infections and nasopharyngitis, with no numerical imbalance between treatment groups. Injection site reactions were reported similarly in the EBGLYSS and placebo arms, with no injection site pain reported.

"Despite the high prevalence of moderate-to-severe atopic dermatitis in infants and young children, they have fewer approved treatment options than adults and adolescents," said Amy Paller, M.D., chair, department of dermatology at Northwestern University and ADorable study investigator. "The topline results from ADorable-1 offer hope for these young patients, delivering near-complete skin clearance and significant itch relief with a highly selective medicine that targets the underlying inflammation that drives this chronic disease."

The ADorable clinical program is ongoing. Additional results from ADorable-1 and ADorable-2, a 52-week extension study of patients enrolled in ADorable-1, will be disclosed later this year.

Lilly continues to raise the standard of care in dermatology and boldly invest in the next wave of immunology innovation, which includes big bets on next-generation modalities, the targeted expansion of small molecules and advancing novel science that uncovers the potential of incretins. Lilly recently shared topline findings from the TOGETHER-PsO and TOGETHER-PsA trials investigating the efficacy and safety of treating adults with psoriatic disease and obesity with both ixekizumab and an incretin-based therapy. Lilly's investigational therapies include DC-853, a novel oral IL-17 inhibitor being studied for psoriasis, and eltrekibart, a novel monoclonal antibody that targets neutrophil-driven inflammation and is being assessed in hidradenitis suppurativa.

Lilly has exclusive rights for development and commercialization of EBGLYSS in the U.S. and the rest of the world outside Europe. Lilly's partner Almirall has licensed the rights to develop and commercialize EBGLYSS for the treatment of dermatology indications, including atopic dermatitis, in Europe.

About ADorable-1
ADorable‑1 (NCT05559359) is a randomized, double‑blind, placebo‑controlled Phase 3 study evaluating the efficacy and safety of EBGLYSS in pediatric patients with moderate-to-severe atopic dermatitis, including infants and children as young as six months. Participants (N=363) were randomized to receive placebo or a weight-based dose of EBGLYSS. Topical corticosteroids were required beginning two weeks before randomization and throughout the 16-week study, but could be decreased or stopped once patients achieved IGA 2 or less. Data from ADorable‑1 are intended to support a potential label expansion of EBGLYSS in younger pediatric populations.

About EBGLYSS 
EBGLYSS is a monoclonal antibody that selectively targets and neutralizes IL-13 with high binding affinity and a slow dissociation rate.3,4,7 EBGLYSS binds to the IL-13 cytokine at an area that overlaps with the binding site of the IL-4Rα subunit of the IL-13Rα1/IL-4Rα heterodimer, preventing formation of this receptor complex and inhibiting IL-13 signaling. IL-13 is implicated as a primary cytokine tied to the pathophysiology of eczema, driving the type-2 inflammatory loop in the skin, and EBGLYSS selectively targets IL-13.7

The EBGLYSS Phase 3 program in atopic dermatitis consists of seven key global studies evaluating over 1,600 patients, including two monotherapy studies (ADvocate 1 and 2), a combination study with topical corticosteroids (ADhere), long-term extension (ADjoin), adolescent open-label (ADore) and pediatric (ADorable 1 and 2) studies. Further data results from ADorable are expected later this year. EBGLYSS is also being studied in allergic rhinitis and chronic rhinosinusitis with nasal polyps.

EBGLYSS was approved in the U.S., Japan and Canada in 2024 and in the European Union in 2023. EBGLYSS is a first-line biologic treatment with the option of monotherapy that offers once-monthly maintenance dosing for adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies.7  EBGLYSS 250 mg/2 mL injection is dosed as a single monthly maintenance injection following the initial phase of treatment. The recommended initial starting dose of EBGLYSS is 500 mg (two 250 mg injections) at Week 0 and Week 2, followed by 250 mg every two weeks until Week 16 or later when adequate clinical response is achieved; after this, maintenance dosing is a single monthly injection (250 mg every four weeks) which can be used with or without topical corticosteroids.7

Lilly is committed to serving patients living with moderate-to-severe atopic dermatitis and is working to enable broad first-line biologic access to EBGLYSS for patients not well controlled with topical prescription therapy through commercial insurance. Lilly has coverage with all three major national pharmacy benefit managers and 94% of commercially insured patients have coverage through national health plans. We have expanded Medicaid coverage and are pursuing similarly broad Medicare coverage as part of Lilly's health equity and affordability initiative. Through Lilly Support Services, Lilly offers a patient support program including co-pay assistance for eligible, commercially insured patients.

INDICATION AND SAFETY SUMMARY 
EBGLYSS® (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. EBGLYSS can be used with or without topical corticosteroids.

It is not known if EBGLYSS is safe and effective in children less than 12 years of age or in children 12 years to less than 18 years of age who weigh less than 88 pounds (40 kg).

Warnings - Do not use EBGLYSS if you are allergic to lebrikizumab-lbkz or to any of the ingredients in EBGLYSS. See the Patient Information leaflet that comes with EBGLYSS for a complete list of ingredients.

Before using
Before using EBGLYSS, tell your healthcare provider about all your medical conditions, including if you:

Have a parasitic (helminth) infection. Are scheduled to receive any vaccinations. You should not receive a "live vaccine" if you are treated with EBGLYSS. Are pregnant or plan to become pregnant. It is not known if EBGLYSS will harm your unborn baby. If you become pregnant during treatment with EBGLYSS, you or your healthcare provider can call Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) to report the pregnancy. Are breastfeeding or plan to breastfeed. It is not known if EBGLYSS passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Possible side effects
EBGLYSS can cause serious side effects, including:

Allergic reactions. EBGLYSS can cause allergic reactions that may sometimes be severe. Stop using EBGLYSS and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing swelling of the face, lips, mouth, tongue or throat hives itching fainting, dizziness, feeling lightheaded skin rash cramps in your stomach area (abdomen) Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. The most common side effects of EBGLYSS include:

eye and eyelid inflammation, including redness, swelling, and itching injection site reactions shingles (herpes zoster) These are not all of the possible side effects of EBGLYSS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

How to take

See the detailed "Instructions for Use" that comes with EBGLYSS for information about how to prepare and inject EBGLYSS and how to properly store and throw away (dispose of) used EBGLYSS prefilled pens and prefilled syringes. Use EBGLYSS exactly as prescribed by your healthcare provider. EBGLYSS is given as an injection under the skin (subcutaneous injection). If your healthcare provider decides that you or a caregiver can give the injections of EBGLYSS, you or a caregiver should receive training on the right way to prepare and inject EBGLYSS. Do not try to inject EBGLYSS until you have been shown the right way by your healthcare provider. In children 12 years of age and older, EBGLYSS should be given by a caregiver. If you miss a dose of EBGLYSS, inject the missed dose as soon as possible, then inject your next dose at your regular scheduled time. Learn more
EBGLYSS is a prescription medicine available as a 250 mg/2 mL injection prefilled pen or prefilled syringe. For more information, call 1-800-545-5979 or go to ebglyss.lilly.com

This summary provides basic information about EBGLYSS but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking to your doctor. Be sure to talk to your doctor or other healthcare provider about EBGLYSS and how to take it. Your doctor is the best person to help you decide if EBGLYSS is right for you.

LK CON BS AD APP

EBGLYSS, its delivery device base, and Lilly Support Services are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. P-LLY

Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about EBGLYSS (lebrikizumab-lbkz) as a treatment for patients with moderate-to severe atopic dermatitis and the timeline for future readouts, presentations, and other milestones relating to EBGLYSS and its clinical trials and reflects Lilly's current beliefs and expectations. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of drug research, development, and commercialization. Among other things, there is no guarantee that future study results will be consistent with the results to date or that EBGLYSS will receive additional regulatory approvals, or that it will be commercially successful. For further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.

1

Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73.

2

Simpson EL, et al. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE). J Am Acad Dermatol. 2018;78(5):863-871.e11. doi:10.1016/j.jaad.2018.01.017

3

Okragly A, et al. Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. Dermatol Ther (Heidelb). 2023;13(7):1535-1547. doi:10.1007/s13555-023-00947-7

4

Ultsch M, et al. Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. J Mol Biol. 2013;425(8):1330-1339. doi:10.10116/j.jmb.2013.01.024

5

Bieber T. Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy. 2020;75(1):54–62. doi:10.1111/all.13954

6

Tsoi LC, et al. Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis. J Invest Dermatol. 2019;139(7):1480-1489. doi:10.1016/j.jid.2018.12.018

7

EBGLYSS. Prescribing Information. Lilly USA, LLC.

SOURCE Eli Lilly and Company